19:50 EDT Biodexa Pharmaceuticals (BDRX) PLC-ADR trading halted, news pending
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested
- Biodexa Pharmaceuticals Announces ADR Ratio Change Effective July 31, 2025
- Biodexa Pharmaceuticals files CTA in Europe for Phase 3 Serenta trial
- Biodexa Pharmaceuticals Announces Successful AGM Resolutions
- Biodexa announces activation of first clinical study site for Serenta trial